ArticlePLoS pathogens2025
Secreted ISG15 induced by Chlamydia trachomatis infection exerts immunomodulatory effects on IFN-γ defense and inflammation.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Human microglia express anti-inflammatory ISG15 in response to Neisseria meningitidis.Neuroscience letters · 2026Article
- Anti-International journal of molecular sciences · 2026Review
- Extracellular Lipopolysaccharide Triggers the Release of Unconjugated Interferon-Stimulated Gene 15 (ISG15) Protein from Macrophages via Type-I Interferon/Caspase-4/Gasdermin-D Pathway.Pathogens (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Interferon-γ (IFN-γ) is an immunoregulatory cytokine essential for cellular immunity against intracellular pathogens, including Chlamydia. Interferon-stimulated gene (ISG) 15, a member of the ubiquitin family, contributes to host resistance to viral and bacterial infections. ISG15 can exist either in an unconjugated form or covalently attached to host proteins through a process known as ISGylation. Here, we show that infection with Chlamydia trachomatis (Ct) induces the expression and secretion of ISG15 in human primary cells and mouse female genital tract (FGT) organoids. ISG15 secretion by genital tract epithelial cells resulted in increased IFN-γ release from natural killer (NK) cells. The production of IFN-γ by NK cells in response to ISG15 was completely abolished in NK cells lacking the interleukin-18 receptor alpha (IL-18Ra), demonstrating a co-stimulatory effect of ISG15 with IL-18 in enhancing IFN-γ release. ISG15 was secreted into the FGT and was involved in controlling bacterial load in a murine infection model. Furthermore, ISG15 reduced macrophage responsiveness to IFN-γ as an M1-polarizing signal for pro-inflammatory responses, potentially "shielding" macrophages from excessive IFN-γ. Evidence of uterine horn pathology and reduced IL-10 levels in the FGT of infected ISG15-/- mice further supports a critical dual function of ISG15 in controlling chlamydial infection and modulating the resulting inflammatory responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.